- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06199648
Digital Solutions for Elderly Care by Informal Caregivers (DigiSECC)
Digital Solutions for Elderly Care by Informal Caregivers: A Study on Nursing Benefits
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background: The majority of elderly people want to live at home, and the home care they need is often provided by informal caregivers. In addition, the number of elderly people is increasing while the number of people who can support them is decreasing. It is therefore important to improve the quality of care and support caregivers. Unfortunately, caregivers are often under heavy strain and the amount of time they can spend receiving advice and support is very limited. Web-based applications could be a solution to address the time needs of caregivers, but little is known about whether such applications are of benefit to the elderly themselves or their caregivers.
Description of the Intervention: A web-based documentation and advice application for home care for elderly people. The intervention is based on the daily status diary, the completion of daily tasks, the writing of short reports (if applicable) and the documentation of the caregiver's constitution. Adherence to the purpose of the web-based application is defined as entering data at least 5 out of 7 days per week.
It is a single-center, open-label, randomized controlled trial with two arms (intervention, control). The study consists of one in person screening visit, two in person study visits and 3 monthly follow-up visits via phone (Visit 0: Screening Visit, Visit 1: Baseline Visit, Visit 2: End of Study Visit, Visit 3: Follow-up). The study-related measurements are: Barthel Index, Short Form of the Late Life Function and Disability Instrument, 5-level EuroQol quality of life questionnaire (EQ-5D-5L), De Morton Mobility Index (DEMMI), individual's general self-efficacy (GSE), user experience questionnaire short form (UEQ-S), Adherence (minimum frequency with which the daily diary was completed by the caregiver). The study begins when both parties in the pair (elderly person and caregiver) sign the informed consent form and ends when the older person dies or the study ends, whichever comes first. The intervention period is 12 weeks.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Sebastian Rosendahl Huber, BScN MScN
- Phone Number: 20034 +43 50344
- Email: Sebastian.Rosendahl-Huber@fhgooe.ac.at
Study Contact Backup
- Name: Ursula Halbmayr-Kubicsek, Mag. Dr. MSc
- Phone Number: 42121 +43 50344
- Email: ursula.halbmayr-kubicsek@fhgooe.ac.at
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Key Inclusion Criteria for the Elderly Person:
- 55 years and older
- Community-dwelling
- Resident in Upper Austria
- Barthel Index below 100
- Requires assistance with activities of daily living
Key Exclusion Criteria for the Elderly Person:
- Planned nursing home admission in the next 12 weeks
- Chronic obstructive pulmonary disease stage III or IV
- Insufficient understanding and judgment to consent to the study
Main Inclusion Criteria for the Caregiver:
- Caregiver of an older person
- Tech savvy
- Committed to using an app to support caregiving
Main Exclusion Criteria for the Caregiver:
- 17 years and younger
- Insufficient insight and judgment to consent to the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Arm A: web-based documentation and advice
|
Caregivers will be supported with a web-based documentation and advice system for home care for elderly people
|
No Intervention: Arm B: Standard of care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean change in function and disability of the elderly participant estimated with Barthel Index (BI)
Time Frame: 104 Weeks
|
The BI assesses the functional status and independence in basic activities of daily living (ADL) of elderly people.
Each domain is scored on a 0-5 or 0-10 scale, with the overall score ranging from 0 to 100.
A higher score represents a higher level of independence.
The BI will be rated by the study staff.
The Hamburg Classification Manual provides detailed criteria for scoring.
|
104 Weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean change in function and disability of the elderly participant estimated with Short Form of the Late-Life Function and Disability Instrument (SF-LLFDI)
Time Frame: 104 Weeks
|
The SF-LLFDI assesses two domains: function and disability, with various subdomains.
It is a self-administered questionnaire that can be completed online or on paper, consisting of 32 items rated on a 5-point Likert scale.
The scores are converted into a percentage of the maximum possible score for each subdomain and domain, with higher scores indicating better function or less disability.
The SF-LLFDI will be self-rated by the elderly participant.
|
104 Weeks
|
Mean change in quality of life of the elderly participant estimated using the 5-item and 5-dimension versions of the EuroQoL questionnaire (EQ-5D-5L)
Time Frame: 104 Weeks
|
The EQ-5D-5L is a patient-reported outcome measure that assesses five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression.
Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems.
The patient is asked to indicate their health status by ticking the box next to the most appropriate statement in each of the five dimensions.
This results in a 5-digit number describing the patient's health.
The EQ-5D-5L is self-reported by the elderly participant.
|
104 Weeks
|
Mean change in mobility of the elderly participant estimated with the de Morton Mobility Index (DEMMI)
Time Frame: 104 Weeks
|
The DEMMI is an advanced instrument designed to measure and monitor changes in mobility for older adults.
It assesses tasks ranging from bed/bedside to dynamic balance and increases in difficulty.
Each task is scored in each category 0, 1, or 2. The raw score maximum total is 19, and the converted score maximum total is 100.
The DEMMI will be rated by a health professional.
|
104 Weeks
|
Mean change in self-efficacy of the elderly participant estimated using the General Self-Efficacy Short Scale (GSE)
Time Frame: 104 Weeks
|
The GSE measures general self-efficacy, which describes an individual's overall confidence in their own competence.
It consists of ten items scored on a 4-point Likert-type scale.
The total score ranges from 10 to 40, with higher scores indicating higher levels of general self-efficacy.
The GSE is self-reported by the elderly participant.
|
104 Weeks
|
Mean change in quality of life of the caregiver estimated with EQ-5D-5L
Time Frame: 104 Weeks
|
The EQ-5D-5L is a patient-reported outcome measure that assesses five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression.
Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems.
The patient is asked to indicate his or her health status by ticking the box next to the most appropriate statement in each of the five dimensions.
This results in a 5-digit number describing the patient's health.
The EQ-5D-5L is self-reported by the caregiver.
|
104 Weeks
|
User experience estimated with the UEQ-S
Time Frame: 1 Hour
|
The UEQ-S measures the overall attractiveness of the web-based application in two domains of user experience: pragmatic quality and hedonic quality.
Pragmatic quality refers to the usability, efficiency and clarity of the web-based application, while hedonic quality refers to the stimulation, interest and novelty of the web-based application.
The UEQ-S is rated by the caregiver.
|
1 Hour
|
Change in status of the caregiver over time estimated with the daily caregiver status diary
Time Frame: 12 Weeks
|
Caregivers rate their experience, effort and positive moments on a daily smiley scale of 1 to 5, with more smileys indicating a better rating.
The data is exported for analysis and is also used to record adverse events related to the elderly person.
|
12 Weeks
|
Adherence by days with no entry in the daily status diary
Time Frame: 12 Weeks
|
Adherence is defined as the degree to which an individual uses an eHealth technology in accordance with the manufacturer's recommendations.
In this study, adherence to the use of the application is assessed by examining the data entered by the caregiver into the daily status diary and the days with no entries.
Adherence is defined as making entries on at least 5 days within a week in 9 out of 12 weeks (i.e.
75%).
|
12 Weeks
|
Survival of the elderly participant based on the number of Grade 5 adverse events in the elderly participant estimated using an adverse event (AE) reporting form.
Time Frame: 104 Weeks
|
Survival based on the number of Grade 5 adverse events experienced by the older participant, as recorded on an AE reporting form.
A higher number of grade 5 adverse events indicates a lower survival rate.
|
104 Weeks
|
Hospitalization rate, with the number of adverse events requiring hospitalization of the elderly participant estimated using an adverse event (AE) reporting form.
Time Frame: 104 Weeks
|
The hospitalization rate is determined based on the number of adverse events requiring hospitalization experienced by the older participant, as recorded on an AE reporting form.
A higher number of AEs reporting hospitalization indicates a higher hospitalization rate.
|
104 Weeks
|
Safety, with number of adverse events estimated using an adverse event (AE) reporting form.
Time Frame: 104 Weeks
|
Safety is determined by the number of adverse events experienced by the elderly participant and recorded on an AE reporting form.
A higher number of adverse events indicates a lower level of safety.
|
104 Weeks
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Christian Mittermaier, Dr., Institute of Physical Medicine and Rehabilitation, Kepler University Hospital, Linz, Austria
- Study Director: Bernhard Schwartz, Dr. BSc MSc, University of Applied Sciences for Health Professions Upper Austria
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- DigiSecc 001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Activities of Daily Living
-
Parker Research InstituteUniversity of Southern Denmark; University College of Northern Denmark; Municipality...Completed
-
Lund UniversityCompletedActivities of Daily Living | Cost Effectiveness | HousingSweden
-
Atılım UniversityNot yet recruitingDUAL TASK | DEGLUTİTİON | COGNİTİVE FUNCTİON | ACTİVİTİES OF DAİLY LİVİNG
-
University of Massachusetts, AmherstCompletedAging | Motor Activity | Activities of Daily Living | WalkingUnited States
-
Centro Hospitalar do PortoUnknownActivities of Daily Living | Hospitalization | Nursing Care | Functional ImpairmentPortugal
-
Ozum Cetinkaya ErenPamukkale University; Akdeniz UniversityCompletedPatient Satisfaction | Activities of Daily Living | Total Hip Replacement | Patient EducationTurkey
-
University of Southern DenmarkCompletedQuality of Life | Cancer | Palliative Care | Activities of Daily Living | Everyday ActivitiesDenmark
-
University of BernUniversity Hospital Inselspital, BerneCompletedNeurodegenerative Diseases | Aging | Activities of Daily LivingSwitzerland
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, FranceCompletedDeath | Activities of Daily Living | Patient AdmissionFrance
-
Mental Health Services in the Capital Region, DenmarkCompletedMood Disorders | Quality of Life | Activities of Daily LivingDenmark
Clinical Trials on web-based documentation and advice
-
US Department of Veterans AffairsCompletedJoint DiseasesUnited States
-
University of Auckland, New ZealandEnrolling by invitation
-
University of Southern DenmarkSygehus Lillebaelt; Nordic Institute of Chiropractic and Clinical Biomechanics and other collaboratorsCompleted
-
Clínica BazterricaWithdrawn
-
University of SouthamptonCompletedType 2 Diabetes
-
Arizona State UniversityUniversity of Colorado, Denver; University of New MexicoUnknownChildhood Obesity | Childhood OverweightUnited States
-
NYU Langone HealthStanford University; Shaare Zedek Medical CenterCompletedAnxiety Disorders | Major Depression | Post Traumatic Stress DisorderIsrael
-
Seattle Children's HospitalCompletedChronic Pain | Headache | Central SensitisationUnited States
-
Georgetown UniversityAlbert Einstein College of Medicine; University of MichiganCompletedTobacco Cessation | Tobacco Use Disorder | Tobacco Use Cessation | Tobacco Dependence | Virus, Human Immunodeficiency | Tobacco-Use DisorderUnited States
-
Henry Ford Health SystemNational Heart, Lung, and Blood Institute (NHLBI)Completed